Li Kang Biomedical Co Ltd (6242) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.004x

Based on the latest financial reports, Li Kang Biomedical Co Ltd (6242) has a cash flow conversion efficiency ratio of -0.004x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-3.17 Million ≈ $-100.00K USD) by net assets (NT$881.47 Million ≈ $27.77 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Li Kang Biomedical Co Ltd market capitalisation for the company's overall valuation and market capitalisation.

Li Kang Biomedical Co Ltd - Cash Flow Conversion Efficiency Trend (2002–2025)

This chart illustrates how Li Kang Biomedical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Li Kang Biomedical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Li Kang Biomedical Co Ltd ranked by their cash flow conversion efficiency. Explore earnings quality score of Li Kang Biomedical Co Ltd to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Kristal Kola ve Mesrubat Sanayi Ticaret AS IS:KRSTL	0.003x
Corem Property Group AB (publ) ST:CORE-A	0.001x
Rich Sparkle Holdings Limited Ordinary Shares NASDAQ:ANPA	-0.004x
JNK Heaters Co. Ltd KQ:126880	0.166x
Nasus Pharma Ltd. NYSE MKT:NSRX	N/A
SWISS PROPERTIES INV.100 F:SR1	N/A
Tamul Multimedia Co. Ltd KQ:093640	-0.041x
Dr Peng Telecom and Media Group Co Ltd SHG:600804	-0.566x

Annual Cash Flow Conversion Efficiency for Li Kang Biomedical Co Ltd (2002–2025)

The table below shows the annual cash flow conversion efficiency of Li Kang Biomedical Co Ltd from 2002 to 2025. View 6242 share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	NT$871.24 Million ≈ $27.45 Million	NT$92.15 Million ≈ $2.90 Million	0.106x	+38.42%
2024-12-31	NT$855.68 Million ≈ $26.96 Million	NT$65.38 Million ≈ $2.06 Million	0.076x	-50.24%
2023-12-31	NT$630.03 Million ≈ $19.85 Million	NT$96.74 Million ≈ $3.05 Million	0.154x	-44.32%
2022-12-31	NT$570.14 Million ≈ $17.96 Million	NT$157.24 Million ≈ $4.95 Million	0.276x	+124.49%
2021-12-31	NT$492.00 Million ≈ $15.50 Million	NT$60.45 Million ≈ $1.90 Million	0.123x	-23.53%
2020-12-31	NT$508.30 Million ≈ $16.01 Million	NT$81.67 Million ≈ $2.57 Million	0.161x	-16.08%
2019-12-31	NT$483.44 Million ≈ $15.23 Million	NT$92.56 Million ≈ $2.92 Million	0.191x	-15.29%
2018-12-31	NT$466.92 Million ≈ $14.71 Million	NT$105.53 Million ≈ $3.32 Million	0.226x	-8.94%
2017-12-31	NT$445.68 Million ≈ $14.04 Million	NT$110.61 Million ≈ $3.48 Million	0.248x	-23.67%
2016-12-31	NT$340.80 Million ≈ $10.74 Million	NT$110.82 Million ≈ $3.49 Million	0.325x	+42.61%
2015-12-31	NT$280.29 Million ≈ $8.83 Million	NT$63.91 Million ≈ $2.01 Million	0.228x	+24.49%
2014-12-31	NT$227.44 Million ≈ $7.17 Million	NT$41.66 Million ≈ $1.31 Million	0.183x	-18.77%
2009-12-31	NT$128.49 Million ≈ $4.05 Million	NT$28.97 Million ≈ $912.65K	0.225x	+1252.82%
2003-12-31	NT$338.06 Million ≈ $10.65 Million	NT$5.63 Million ≈ $177.50K	0.017x	-87.37%
2002-12-31	NT$347.64 Million ≈ $10.95 Million	NT$45.87 Million ≈ $1.45 Million	0.132x	--

About Li Kang Biomedical Co Ltd

TWO:6242 Taiwan Travel Services

Market Cap

$33.97 Million

NT$1.08 Billion TWD

Market Cap Rank

#23420 Global

#1455 in Taiwan

Share Price

NT$33.90

Change (1 day)

+0.30%

52-Week Range

NT$33.60 - NT$41.30

All Time High

NT$13364.93